(Q39400640)

11 September 2017

title

Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice (English)

1 reference

11 September 2017

Pierre L Triozzi

1

1 reference

11 September 2017

Wayne Aldrich

2

1 reference

11 September 2017

Susan Achberger

3

1 reference

11 September 2017

Selvarangan Ponnazhagan

4

1 reference

11 September 2017

Oscar Alcazar

5

1 reference

11 September 2017

Yogen Saunthararajah

6

1 reference

11 September 2017

language of work or name

1 reference

5 February 2012

1 reference

Cancer Immunology, Immunotherapy

11 September 2017

published in

1 reference

11 September 2017

volume

61

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1441-1450

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1204-x

11 September 2017

exact match

0 references

cites work

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Epigenetic regulation of immune escape genes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Epigenetic events in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Use of epigenetic modification to induce FOXP3 expression in naïve T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

T-bet plays a key role in NK-mediated control of melanoma metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Control of organ-specific demethylation by an element of the T-cell receptor-alpha locus control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

Role of CD4(+)CD25(+) T regulatory cells in IL-2-induced vascular leak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1204-X

10.1007/S00262-012-1204-X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference